Lincoln Pharmaceuticals Ltd

NSE
LINCOLN •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in Lincoln Pharmaceuticals Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
New 52W High in past week
0.4
TTM PE Ratio
Below industry Median
15.6
Price to Book Ratio
Below industry Median
2.7
Dividend yield 1yr %
Low in industry
0.2
TTM PEG Ratio
PEG TTM is less than 1
0.7
RSI
RSI is mid-range
51.7
MFI
MFI Overbought
74.7

Lincoln Pharmaceuticals Ltd Key Financials

*All values are in ₹ Cr.

Lincoln Pharmaceuticals Ltd shareholding Pattern

Promoter
49.8%
Foreign Institutions
3.2%
Domestic Institutions
0.1%
Public
46.9%

Lincoln Pharmaceuticals Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
11
Bearish Moving Averages
5
5Day EMA
688.00
10Day EMA
687.80
12Day EMA
686.20
20Day EMA
679.60
26Day EMA
675.40
50Day EMA
659.60
100Day EMA
622.00
200Day EMA
555.40
Delivery & Volume
Resistance & Support
680.55
Pivot
Resistance
First Resistance
689.90
Second Resistance
699.30
Third Resistance
708.65
Support
First Support
671.15
Second support
661.80
Third Support
652.40
Relative Strength Index
51.71
Money Flow Index
74.73
MACD
10.83
MACD Signal
11.07
Average True Range
30.79
Average Directional Index
23.24
Rate of Change (21)
4.49
Rate of Change (125)
33.44

Lincoln Pharmaceuticals Ltd Company background

Founded in: 1995
Managing director: Mahendra G Patel
Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. 95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The company was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals.The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake inhouse testing of its products for better quality control and RD. It came out with a public issue in Feb.96 to partfinance its project.The Company launched Next Generation Progesterone Therapy ProlinSpray during the year 2018. During the year 202122, Lincoln Parenteral Limited (Transferor Company), an erstwhile subsidiary, merged with Lincoln Pharmaceuticals Limited (the Transferee Company) through the Scheme of Amalgamation and consequent to this, the Transferor Company ceases to be the subsidiary of the Company. The Company acquired a plant in Mehsana, Gujarat to launch Cephalosporin products in 2022.
Read More

Lincoln Pharmaceuticals Ltd FAQs

Lincoln Pharmaceuticals Ltd shares are currently priced at 680.5 on NSE and 680.2 on BSE as of 3/1/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Lincoln Pharmaceuticals Ltd [LINCOLN] share was 103.89. The Lincoln Pharmaceuticals Ltd [LINCOLN] share hit a 1-year low of Rs. 319.25 and a 1-year high of Rs. 755.15.

The market cap of Lincoln Pharmaceuticals Ltd is Rs. 1363.02 Cr. as of 3/1/2024 12:00:00 AM.

The PE ratios of Lincoln Pharmaceuticals Ltd is 15.61 as of 3/1/2024 12:00:00 AM.

The PB ratios of Lincoln Pharmaceuticals Ltd is 2.49 as of 3/1/2024 12:00:00 AM

You can easily buy Lincoln Pharmaceuticals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage